Harpoon Therapeutics, Inc. — Form D

Harpoon Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-11-26. The offering totals $70.0M, of which $70.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
Patrick R BaeuerleDirectorSouth San Francisco, CA
Mark R ChinDirectorSouth San Francisco, CA
Jonathan R DrachmanDirectorSouth San Francisco, CA
Julie R EastlandDirectorSouth San Francisco, CA
Luke R EvninDirectorSouth San Francisco, CA
Ron R HuntDirectorSouth San Francisco, CA
Gerald McMahonDirectorSouth San Francisco, CA
Scott R MyersDirectorSouth San Francisco, CA
Georgia L ErbezExecutive OfficerSouth San Francisco, CA
Gerald McMahonExecutive OfficerSouth San Francisco, CA
Natalie R SacksExecutive OfficerBerkeley, CA
Holger R WescheExecutive OfficerSouth San Francisco, CA
Alan ColowickDirectorBelmont, CA
Luke WalkerExecutive OfficerNashville, TN
Andrew RobbinsDirectorNew York, NY
Joseph BailesDirectorHouston, TX
Julie EastlandDirectorSouth San Francisco, CA
Julie EastlandExecutive OfficerSouth San Francisco, CA
Mark ChinDirectorCambridge, MA
Scott MyersDirectorSouth San Francisco, CA
Jonathan DrachmanDirectorSouth San Francisco, CA
Ronald HuntDirectorSouth San Francisco, CA
Lauren SilvernailDirectorSouth San Francisco, CA
Joanne P VineyDirectorSouth San Francisco, CA
Luke Nathaniel WalkerExecutive OfficerSouth San Francisco, CA

Other filings by this issuer (3)

FiledFormOfferingSold
2023-10-31D$100.2M$100.2M
2023-04-07D$25.0M$25.0M
2017-06-06D$45.2M$25.2M

More